The European Medicines Agency has produced a video with an introduction to the new pharmacovigilance legislation. Watch Dr Peter Arlett, Head of Pharmacovigilance and Risk Management, talking about the new and improved tools for regulators in Europe to ensure that patients are not exposed to unnecessary risks when taking medicines.

The new pharmacovigilance legislation came into operation on 2 July 2012. Its aim is to promote and protect public health by strengthening the existing Europe-wide system for monitoring the safety and benefit-risk balance of medicines.

Source and video

Related GMP News
25/04/2013	FDA offers eLearning for eCTD Implementation
25/04/2013	EMA publishes Updated Procedural Advice for Centralised Marketing Authorisations
25/04/2013	CTD Format for Traditional Herbal Medicinal Products
03/04/2013	Simplification of Application Submissions for Centrally Authorised Products
03/04/2013	WHO's New Draft Guideline on Submission of Quality Data for Generic Medicinal Products